23andMe founder Anne Wojcicki will regain management of embattled DNA firm in any case

In a shock twist, 23andMe founder and former CEO Anne Wojcicki is ready to regain management of the DNA firm’s property, according to a press release from 23andMe. In Could, an organization known as Regeneron bought 23andMe for $256 million in a chapter public sale, however Wojcicki’s nonprofit, TTAM Analysis Institute, was capable of reopen bidding with an “unsolicited provide” of $305 million, The Wall Street Journal reports.

A chapter decide agreed to reopen bidding on 23andMe beneath the situation that Regeneron high Wojcicki’s proposed value by at the least $10 million, based on WSJ. Regeneron declined, leaving 23andMe in TTAM’s management assuming the decide approves the deal. A listening to to contemplate the brand new deal is ready for June 17, 2025.

Regeneron had beforehand deliberate to maintain on the entire firm’s staff and proceed providing client DNA testing kits. Apart from answering clients’ questions on their ancestry, 23andMe’s genetic knowledge is effective as a solution to establish potential well being dangers, and within the case of Regeneron, as a device for figuring out drug targets.

It is not utterly clear what Wojcicki intends to do subsequent, however 23andMe’s announcement features a record of buyer knowledge and privateness protections TTAM Analysis Institute has agreed to, together with persevering with to permit clients to delete their knowledge and opt-out of analysis, establishing a Client Privateness Advocacy Board and promising to “not promote or switch genetic knowledge” within the occasion of one other chapter — except the client agrees to the identical privateness protections.

Sustaining management of the corporate’s property has been Wojcicki’s plan since 23andMe declared bankruptcy in March 2025. She initially resigned as the corporate’s CEO to make a bid on the corporate.

“I’m thrilled that TTAM Analysis Institute will be capable of proceed the mission of 23andMe to assist individuals entry, perceive and profit from the human genome,” Wojcicki says. “We consider it’s important that people are empowered to have alternative and transparency with respect to their genetic knowledge and have the chance to proceed to study their ancestry and well being dangers as they need.”

23andMe had a turbulent few years previous to declaring chapter, struggling an information breach in 2023 that impacted millions of customers and mass layoffs in 2024 that affected 40 percent of the corporate’s workers.

In case you purchase one thing via a hyperlink on this article, we could earn fee.